Cancer is costly for patients and the NHS—but it also has a significant impact on the U.K. economy, according to research led ...

A cancer specialist at Weston Park Cancer Centre has won a national award following a public vote for her outstanding ...

People dying early due to cancer costs the UK economy £10.3 billion every year, according to the most comprehensive analysis ...

As part of the 10 Year Health Plan, the UK Government has announced it will offer home-testing kits for cervical cancer ...

New plans have been announced to shake up the way cervical cancer risk is detected in England: at-home HPV testing kits are ...

Research at the Cancer Research UK Manchester Institute spans the spectrum of cancer ... Chief Executive of The Christie NHS Foundation Trust, Roger Spencer, said: “We are very excited to welcome ...

In June, 2025, the UK government announced plans to boost science and technology research and development (R&D) in the country, pledging to invest £86 billion in the sector over the next 4 years. The ...

Nearly one in three women and other people with a cervix in the UK don’t attend their cervical screening when invited. Yet ...

Truqap was approved in the UK in July 2024 based on the 708-subject CAPItello-291 study, which included 289 patients with tumours that had an abnormal PIK3CA, AKT1 or PTEN gene.

The first targeted drug for a common form of bladder cancer that can be taken at home has been backed for NHS use, offering hope of simpler treatment to hundreds of patients in England.

By 2030, every baby born in the UK could have their entire genome sequenced under a new NHS initiative to “predict and ...

Cancer models are naturally existing or artificially induced systems that share features with human cancers. Experimental systems for studying human cancer include cell lines and organisms such as ...